Antitumor effects of the multi-target tyrosine kinase inhibitor cabozantinib: a comprehensive review of the preclinical evidence-Reference-Cited by-同舟云学术

Antitumor effects of the multi-target tyrosine kinase inhibitor cabozantinib: a comprehensive review of the preclinical evidence

Author:

Santoni Matteo¹,Iacovelli Roberto²,Colonna Valentina³,Klinz Stephan⁴,Mauri Giorgio⁵,Nuti Marianna⁶

Affiliation:

1. MD, U.O.C. Medical Oncology, Macerata Hospital, Macerata, Italy

2. Medical Oncologist, Medical Oncology Unit, Fondazione Policlinico Agostino Gemelli IRCCS, Roma, Italy

3. Global Medical Development Director, Global Oncology R&D, Ipsen S.p.A., Milano, Italy

4. Senior Director, Translational Medicine & Biomarkers, Ipsen, United States, MA, USA

5. Medical Advisor Oncology, Ipsen S.p.A., Milano, Italy

6. Professor, Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

Funder

Ipsen

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

Reference103 articles.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献